» Articles » PMID: 2542372

Changes in Lymphocyte Beta-adrenergic Receptor Density and Noradrenaline Content of the Spleen Are Early Indicators of Immune Reactivity in Acute Experimental Allergic Encephalomyelitis in the Lewis Rat

Overview
Journal J Neuroimmunol
Specialty Neurology
Date 1989 Jul 1
PMID 2542372
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Neural activity in the spleen in the pre-clinical stage of experimental allergic encephalomyelitis (EAE) mirrored that of animals immunized with complete Freund's adjuvant (CFA) alone. In response to immune challenge the splenic noradrenaline content fell significantly, accompanied by an increase in lymphocyte beta-receptor density. The response of the pituitary-adrenal axis was reflected in increased circulating levels of corticosterone in both experimental groups; this was amplified by the stress of clinical signs leading to a 2-fold increase in animals with EAE. The increased, potentially immunosuppressive concentration of noradrenaline in the spleen during the acute stage may also represent a recovery mechanism and indicate how neuroimmune interactions could influence the relapsing-remitting nature of chronic inflammatory demyelinating disease.

Citing Articles

Early-life-trauma triggers interferon-β resistance and neurodegeneration in a multiple sclerosis model via downregulated β1-adrenergic signaling.

Khaw Y, Majid D, Oh S, Kang E, Inoue M Nat Commun. 2021; 12(1):105.

PMID: 33397973 PMC: 7782805. DOI: 10.1038/s41467-020-20302-0.


Role of the End-Point Mediators of Sympathoadrenal and Sympathoneural Stress Axes in the Pathogenesis of Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.

Pilipovic I, Stojic-Vukanic Z, Prijic I, Leposavic G Front Endocrinol (Lausanne). 2020; 10:921.

PMID: 31993021 PMC: 6970942. DOI: 10.3389/fendo.2019.00921.


G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Du C, Xie X Cell Res. 2012; 22(7):1108-28.

PMID: 22664908 PMC: 3750109. DOI: 10.1038/cr.2012.87.


Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology.

Dhabhar F Neuroimmunomodulation. 2009; 16(5):300-17.

PMID: 19571591 PMC: 2790771. DOI: 10.1159/000216188.


Sympathetic modulation of immunity: relevance to disease.

Bellinger D, Millar B, Perez S, Carter J, Wood C, ThyagaRajan S Cell Immunol. 2008; 252(1-2):27-56.

PMID: 18308299 PMC: 3551630. DOI: 10.1016/j.cellimm.2007.09.005.